Fitgurú on MSN
Could a Blood Test for Alzheimers Also Reveal Hidden Heart and Kidney Diseases? Scientists Make a Surprising Discovery
New research suggests a blood protein linked to Alzheimer’s may also help detect other serious conditions affecting the heart and kidneys, opening new possibilities for early diagnosis.
A certain blood protein regarded as an early indicator of Alzheimer's disease also appears to play a role in other disorders.
A certain blood protein regarded as an early indicator of Alzheimer's disease also appears to play a role in other disorders.
But here's why you likely won't be seeing it in your doctor's office anytime soon.
What if we could repair fundamental parts of our bodies? Gene therapy promises just that. It's like having a molecular mechanic that can fix or replace faulty genes, potentially curing diseases ...
Scientists develop a blood test that detects Alzheimer’s by measuring protein structural changes rather than protein quantity.
What if doctors could tell you a disease was coming years before you felt a single symptom—and stop it in its tracks? That is ...
Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...
Health and Me on MSN
Obesity, diabetes, and kidney disease: The dangerous health triangle
Obesity is a serious health issue that increases the risk of developing diabetes and increases the risk of diabetic kidney ...
It’s now possible to treat inherited blood diseases, such as sickle cell disease, with gene editing. Blood stem cells are extracted from the patient, modified, and infused back into their bone ...
A new blood test uses a portable diagnostic system to detect various different diseases in just 15 minutes. The test could change the way we diagnose a wide range of infectious diseases. Here's what ...
Sanofi’s Enjaymo, the only approved drug therapy for a rare and debilitating blood disorder, is being acquired by Recordati in a deal that helps the Italian company build its rare disease portfolio ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results